IDEC PHARMACEUTICALS CORPORATION
Patent Owner
Stats
- 5 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Feb 19, 2009 most recent publication
Details
- 5 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 839 Total Citation Count
- Jun 07, 1995 Earliest Filing
- 10 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6682734 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaJun 07, 95Jan 27, 04[A61K, C07K]
RE38008 Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereofNov 29, 01Feb 25, 03[A61K]
6399061 Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphomaJun 07, 95Jun 04, 02[A61K, C07K]
5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaJun 07, 95Dec 01, 98[A61K, C07K]
5776456 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaJun 07, 95Jul 07, 98[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2009/0047,668 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the sameAbandonedJun 25, 07Feb 19, 09[C12Q, C12N]
7235360 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the sameExpiredApr 06, 04Jun 26, 07[C12Q]
2005/0123,540 Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applicationsAbandonedSep 29, 04Jun 09, 05[A61K]
2004/0258,616 Compositions and methods for treating cancer using IGSF9 and LIV-1AbandonedJan 27, 04Dec 23, 04[A61K, C07K]
2004/0213,784 Use of chimeric anti-CD20 antibody as in vitro or in vivo purging agent in patients receiving BMT or PBSC transplantAbandonedMay 21, 04Oct 28, 04[A61K]
6736168 Fiber reinforced plastic pipe and filament winding apparatusExpiredMar 25, 02May 18, 04[F16L]
2003/0206,903 Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibodyAbandonedMay 19, 03Nov 06, 03[A61K]
2003/0026,804 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodyAbandonedJul 17, 02Feb 06, 03[A61K]
2003/0020,091 Structure and method for fabricating an optical switch utilizing the formation of a compliant substrateAbandonedJul 25, 01Jan 30, 03[H01L]
2003/0021,781 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaAbandonedJul 17, 01Jan 30, 03[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.